Fu Gui

1.2k total citations
25 papers, 592 citations indexed

About

Fu Gui is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Fu Gui has authored 25 papers receiving a total of 592 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in Fu Gui's work include PARP inhibition in cancer therapy (4 papers), DNA Repair Mechanisms (2 papers) and Microbial Natural Products and Biosynthesis (2 papers). Fu Gui is often cited by papers focused on PARP inhibition in cancer therapy (4 papers), DNA Repair Mechanisms (2 papers) and Microbial Natural Products and Biosynthesis (2 papers). Fu Gui collaborates with scholars based in China, United States and Japan. Fu Gui's co-authors include Yulan Zhang, Hongxi Wu, Zhipeng You, Shuhua Fu, Zhengdong Hong, Jia Li, Adam S. Kibel, Tomoaki Takai, Yuanjue Wu and Runming Jin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Brain Research.

In The Last Decade

Fu Gui

24 papers receiving 585 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fu Gui China	12	218	119	88	81	79	25	592
Qian Ma China	15	274 1.3×	38 0.3×	91 1.0×	86 1.1×	57 0.7×	40	726
Emily Brook Australia	11	139 0.6×	113 0.9×	16 0.2×	90 1.1×	44 0.6×	15	509
Sang Yeop Kim United States	9	301 1.4×	34 0.3×	130 1.5×	57 0.7×	30 0.4×	19	622
Orhan Baykal Türkiye	14	125 0.6×	46 0.4×	190 2.2×	40 0.5×	29 0.4×	34	561
Rakeshwar S. Guleria United States	17	404 1.9×	35 0.3×	12 0.1×	101 1.2×	64 0.8×	25	722
Elli F. Kamper Greece	15	167 0.8×	65 0.5×	12 0.1×	120 1.5×	32 0.4×	26	767
Lun Cai China	12	201 0.9×	83 0.7×	9 0.1×	66 0.8×	37 0.5×	31	656
Fernándo López-Barrera Mexico	12	204 0.9×	51 0.4×	25 0.3×	70 0.9×	13 0.2×	16	677
Jing Meng China	13	116 0.5×	179 1.5×	33 0.4×	77 1.0×	59 0.7×	35	547
Raid Saleem Al-Baradie Saudi Arabia	12	212 1.0×	63 0.5×	10 0.1×	71 0.9×	56 0.7×	24	512

Countries citing papers authored by Fu Gui

Since Specialization

Citations

This map shows the geographic impact of Fu Gui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fu Gui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fu Gui more than expected).

Fields of papers citing papers by Fu Gui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fu Gui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fu Gui. The network helps show where Fu Gui may publish in the future.

Co-authorship network of co-authors of Fu Gui

This figure shows the co-authorship network connecting the top 25 collaborators of Fu Gui. A scholar is included among the top collaborators of Fu Gui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fu Gui. Fu Gui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gui, Fu, Baishan Jiang, Jie Jiang, et al.. (2025). Acute BRCAness induction and AR pathway blockage through CDK12/7/9 degradation enhances PARP inhibitor sensitivity in prostate cancer. Science Advances. 11(17). eadu0847–eadu0847. 2 indexed citations

Sun, Wenlong, Fu Gui, Marcus Ruscetti, et al.. (2025). SPARC: A Multipayload ADC Architecture for Programmable Drug Combinations. Bioconjugate Chemistry. 36(10). 2158–2171.

Xiong, Jian, Jingjing Xu, Xiaolong Yin, et al.. (2024). Mesopic pupil indices as potential risk factors for glare disability after intraocular implantable collamer lens implantation: prospective study. Journal of Cataract & Refractive Surgery. 50(6). 565–571. 1 indexed citations

Tsujino, Takuya, Tomoaki Takai, Chenkui Miao, et al.. (2023). Abstract PR014: Genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer. Cancer Research. 83(11_Supplement). PR014–PR014. 1 indexed citations

Miao, Chenkui, Takuya Tsujino, Tomoaki Takai, et al.. (2022). RB1 loss overrides PARP inhibitor sensitivity driven by RNASEH2B loss in prostate cancer. Science Advances. 8(7). eabl9794–eabl9794. 25 indexed citations

Gao, Weiyin, Shouhua Zhang, Guorong Li, et al.. (2022). Nc886 promotes renal cancer cell drug-resistance by enhancing EMT through Rock2 phosphorylation-mediated β-catenin nuclear translocation. Cell Cycle. 21(4). 340–351. 15 indexed citations

Gao, Weiyin, et al.. (2022). miR‑5590‑3p inhibits the proliferation and metastasis of renal cancer cells by targeting ROCK2 to inhibit proliferation, migration and invasion. Oncology Letters. 24(4). 377–377. 4 indexed citations

Wan, Jianhua, Jiale Wang, Larry E. Wagner, et al.. (2021). Pancreas-specific CHRM3 activation causes pancreatitis in mice. JCI Insight. 6(17). 10 indexed citations

Li, Yan, Yanyan Ge, Yuxin Shi, et al.. (2021). Role of Prealbumin in Predicting the Prognosis of Severely and Critically Ill COVID-19 Patients. American Journal of Tropical Medicine and Hygiene. 105(3). 718–726. 9 indexed citations

10.

Gui, Fu, Zhipeng You, Shuhua Fu, Hongxi Wu, & Yulan Zhang. (2020). Endothelial Dysfunction in Diabetic Retinopathy. Frontiers in Endocrinology. 11. 591–591. 129 indexed citations

11.

Gui, Fu, Wenjing Zhang, Jing Dai, et al.. (2019). Increased Peripheral Interleukin 10 Relate to White Matter Integrity in Schizophrenia. Frontiers in Neuroscience. 13. 52–52. 28 indexed citations

12.

Lv, Peilin, Fei Li, Wenjing Zhang, et al.. (2019). Association of peripheral cytokine levels with cerebral structural abnormalities in schizophrenia. Brain Research. 1724. 146463–146463. 35 indexed citations

13.

Fu, Yuchuan, Yuan Xiao, Fu Gui, et al.. (2019). Brain Structural Alterations in Left-Behind Children: A Magnetic Resonance Imaging Study. Frontiers in Neural Circuits. 13. 33–33. 7 indexed citations

14.

Gui, Fu, Jie Jiang, Zhixiang He, et al.. (2019). A non‐covalent inhibitor XMU‐MP‐3 overrides ibrutinib‐resistant Btk^C481S mutation in B‐cell malignancies. British Journal of Pharmacology. 176(23). 4491–4509. 17 indexed citations

15.

Gui, Bin, Fu Gui, Tomoaki Takai, et al.. (2019). Selective targeting of PARP-2 inhibits androgen receptor signaling and prostate cancer growth through disruption of FOXA1 function. Proceedings of the National Academy of Sciences. 116(29). 14573–14582. 81 indexed citations

16.

Gui, Fu, Zhengdong Hong, Zhipeng You, Hongxi Wu, & Yulan Zhang. (2016). MiR‐21 inhibitor suppressed the progression of retinoblastoma via the modulation of PTEN/PI3K/AKT pathway. Cell Biology International. 40(12). 1294–1302. 34 indexed citations

17.

Guo, Kai, et al.. (2016). Two New Ring A‐Cleaved Lanostane‐Type Triterpenoids and Four Known Steroids Isolated from Endophytic Fungus Glomerella sp. F00244. Helvetica Chimica Acta. 99(8). 601–607. 7 indexed citations

18.

Zhan, Ying, Nanwen Zhang, Anan Wu, et al.. (2015). Aspertetranones A–D, Putative Meroterpenoids from the Marine Algal-Associated Fungus Aspergillus sp. ZL0-1b14. Journal of Natural Products. 78(10). 2405–2410. 25 indexed citations

19.

Wang, Chang‐Yun, et al.. (2010). Clinical study of AcrySof(R) Toric intraocular lens implantation on corneal astigmatism. 28(8). 881–883. 1 indexed citations

20.

Gui, Fu. (2008). Progress and Prospect on the Studies of Fish Myosin Heavy Chain and its Genes. Letters in Biotechnology. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact